PubMed

Um Análise Completa de Ordens de Estudos de Vigilância Pós-Mercado: Características do Dispositivo, Status dos Estudos, Resultados e Contribuições Potenciais.

PMID: 31997227 · 2020-01-29

C, h, i, e, , I, w, a, i, s, h, i, ;, , K, i, y, o, t, a, k, a, , I, w, a, s, a, k, i

RevistaTherapeutic innovation & regulatory science

Ano2020-01-29

PMID31997227

Resumo

The postmarket surveillance system plays a vital role in managing residual risks and identifying safety signals in real-world clinical practice. The Food and Drug Administration (FDA) can order postmarket surveillance studies when safety concerns are raised. We conducted a thorough investigation of device characteristics, study statuses, and the outcomes of US postmarket surveillance studies. As of April 2017, we identified 338 orders, corresponding to 394 studies using the FDA database. Additio

Fonte oficial

Ver no PubMed →

Dados provenientes do PubMed / NCBI. Para consultar o texto integral e as informações mais recentes, recorra sempre ao registo oficial.